Cognate Bioservices, Inc.
Records under this name other than patents Cognate Bioservices, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Cognate Bioservices, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,708,985 | Glycosylated IL-7, preparation and uses Formerly held Term ended Term ended Jul 19, 2026 · From the USPTO record | Term ended | Term ended Jul 19, 2026 | From the USPTO record |
| US 8,034,327 | Hyperglycosylated IL-7, preparation and uses Formerly held Term ended Ended no later than Jul 19, 2026 · From the USPTO record | Term ended | Ended no later than Jul 19, 2026 | From the USPTO record |
| US 8,153,114 | Hyperglycosylated mammalian IL-7 IgG conjugate composition Formerly held Term ended Term ended Jul 19, 2026 · From the USPTO record | Term ended | Term ended Jul 19, 2026 | From the USPTO record |
| US 7,585,947 | IL-7 drug substance, composition, preparation and uses Formerly held Term ended Term ended Mar 23, 2024 · From the USPTO record | Term ended | Term ended Mar 23, 2024 | From the USPTO record |
| US 9,249,393 | Adipose Derived Adult Stem Cells in Hepatic Regeneration Lapsed on the fee record Ended Feb 2, 2024 · High confidence | Lapsed on the fee record | Ended Feb 2, 2024 | High confidence |
| US 6,555,374 | Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof Term ended Term ended Dec 10, 2020 · From the USPTO record | Term ended | Term ended Dec 10, 2020 | From the USPTO record |
| US 9,408,876 | Liver stromal cells for prevention and treatment of immune responses in transplantation Lapsed on the fee record Ended Aug 9, 2020 · From the USPTO record | Lapsed on the fee record | Ended Aug 9, 2020 | From the USPTO record |
| US 6,242,200 | Screening for SUR1 antagonists using adipocytes Term ended Term ended Jun 12, 2020 · From the USPTO record | Term ended | Term ended Jun 12, 2020 | From the USPTO record |
| US 6,391,297 | Differentiation of adipose stromal cells into osteoblasts and uses thereof Term ended Term ended May 19, 2020 · From the USPTO record | Term ended | Term ended May 19, 2020 | From the USPTO record |
| US 6,429,013 | Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair Term ended Term ended May 17, 2020 · From the USPTO record | Term ended | Term ended May 17, 2020 | From the USPTO record |